[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334344-105":59,"doc-detail-334344-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","innovative-bacterial-therapies-and-genetic-engineering-approaches-in-colorectal-cancer-a-review-of-emerging-strategies-and-clinical-implications","Innovative Bacterial Therapies and Genetic Engineering Approaches in Colorectal Cancer - A Review of Emerging Strategies and Clinical Implications","","Colorectal cancer (CRC) is a major global health burden with limited survival when diagnosed at advanced stages. Conventional surgery, chemotherapy, and irradiation face major obstacles including drug resistance and toxicity, motivating the search for emerging modalities. This review highlights bacterial-based strategies such as engineered bacteriophage therapy and bacterial immunotherapy, aiming for effective tumor-cell killing with reduced harm, alongside molecular genetic engineering approaches including CRISPR-Cas9, CRISPR prime editing, and gene silencing to improve CRC targeting. It also considers clinical implications and associated risks like immune reactions and gene transfer.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/innovative-bacterial-therapies-and-genetic-engineering-approaches-in-colorectal-cancer-a-review-of-emerging-strategies-and-clinical-implications/334344/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/innovative-bacterial-therapies-and-genetic-engineering-approaches-in-colorectal-cancer-a-review-of-emerging-strategies-and-clinical-implications/334344.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What challenges and risks are associated with bacterial therapies?","Question",{"text":112,"@type":113},"The review notes immune reactions such as inflammation or systemic infection, and the possibility of gene transfer that could create harmful genetically modified bacterial strains.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},334344,1790221059,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":36,"preview_page_count":4},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","J. Microbiol. Biotechnol. 2024. 34(12): 2397–2412 [https://doi.org/10.4014/jmb.2408.08026](https://doi.org/10.4014/jmb.2408.08026)  \nReview  \nReceived: September 3, 2024  \nAccepted: September 20, 2024  \nFirst published online: September 25, 2024  \n*Corresponding author  \n[E-mail: chunwuZhao@outlook. com](E-mail: chunwuZhao@outlook. com)  \n[pISSN 1017-7825](pISSN 1017-7825)[ ](pISSN 1017-7825)[eISSN 1738-8872](eISSN 1738-8872)  \nCopyright © 2024 by the authors. Licensee KMB. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nInnovative Bacterial Therapies and Genetic Engineering Approaches in Colorectal Cancer: A Review of Emerging Strategies and Clinical Implications  \nChunxiao Song1 and Chunwu Zhao2*  \n1Department of Colorectal and Anal Surgery, Weifang People's Hospital, Weifang 261000, P. R. China 2Department of Gastrointestinal Surgery, Weifang People's Hospital, Weifang 261000, P. R. China  \nColorectal cancer (CRC) is considered a widespread cancer, ranking second in mortality and incidence among cancer patients worldwide. CRC develops from adenoma to carcinoma through the dynamic interplay of genetic and environmental factors. The conventional modes of treatment, including operation, chemotherapy, and irradiation, are associated with significant challenges, such as drug resistance and toxicity, necessitating the exploration of new treatment modalities. These difficulties reveal the necessity of the emergence of new therapeutic approaches. This review mainly emphasizes the bacterial-based therapies that have recently developed like the engineered bacteriophage therapy and bacterial immunotherapy that pale the existing chemotherapy in terms of toxicity but are effective in killing tumor cells. Also, it also investigates various molecular genetic engineering strategies such as CRISPR-Cas9, CRISPR prime editing and gene silencing to achieve better targeting of CRC. Implementing these new approaches into the forefront of CRC treatment may bring better, more effective therapy with fewer side effects on patients’ quality of life.  \nKeywords: Microbiota, bacteriophage therapy, genetic engineering, chromosome instability, CRISPR-Cas9  \nIntroduction  \nColorectal cancer (CRC) is a significant global health problem since it ranks second among the prominent causes of cancer-related mortalities globally [1]. This disease is common in men and women, and the survival rate for five years is comparatively less and estimated tobe 65%[1]. When diagnosed, this rate depends on the disease's stage [1]. CRC is a cancer that initiates in the colon or rectum, a section of the large intestine. It starts from a polyp, which is a noncancerous tumor that may grow into a malignant tumor overtime [2]. This pathological condition is frequently asymptomatic for many years and is diagnosed in the late stage, which results in a poor prognosis. The manifestation includes frequent changes in bowels, diarrhea, constipation, the urge to defecate, abdominal pain, sometimes passing of bright red blood, either concealed or visible, loss of weight, pain in the abdomen, tiredness, and exhaustion [3]. However, such signs and symptoms are often ignored, and patients do not present themselves to the hospital until the disease is well established, hence the need for regular checkups and screening. This is because the given measures can assist in increasing the success rate of early detection and effective management of the condition [3] .  \nPoor lifestyles, heredity factors, and an undesired diet plan make the populace vulnerable to CRC [4] . The dynamics involved are these layers of regulation of complex genetic mutations and cogent epigenetic modifications that drive the progress of the disease [5] . Knowledge of these risk factors and the molecular processes underlying CRC will provide a platform for developing effective prevention, early screening, and intercession treatment.  \nTh","cbCaihKP1o9KdcBR","https://ap.wps.com/l/cbCaihKP1o9KdcBR","pdf",2297410,16,"English","# Introduction\n## Colorectal cancer burden and clinical features\n## Risk factors and molecular mechanisms\n## Role of colonic microbiota in cancer\n## Rationale for bacterial therapies\n# Emerging bacterial and genetic engineering strategies\n## Engineered bacteriophage therapy and bacterial immunotherapy\n## CRISPR-Cas9, prime editing, and gene silencing approaches\n## Clinical implications and challenges","[{\"question\":\"What challenges and risks are associated with bacterial therapies?\",\"answer\":\"The review notes immune reactions such as inflammation or systemic infection, and the possibility of gene transfer that could create harmful genetically modified bacterial strains.\"}]","Innovative Bacterial Therapies and Genetic Engineering Approaches in Colorectal Cancer - A Review of Emerging Strategies and Clinical Implications | PDF",1790006325]